advancedamongbeyondcancercarecervicalchemotherapychoiceclinicalcomplicationsdiverteditorendometrialfactorsfinancialfollowfollowingfuturegoodgradeimpactinhibitorlonglookinglowlymphmolecularneoadjuvantnodeovarianparppatientspracticeprimaryrecurrentsentinelseroussocietystagestudysurgerysurgicalsurvivaltestingtherapytoxicitiestreatmenttrialtrophoblasticupdatesvulvarwomen